Larvol Delta - New-PKPD-Analysis-and-Phase-2-Study-Results-for-Neflamapimod-80-mg-BID-in-DLB-Strengthen-Understanding-of-Dosing

neflamapimod (VX-745) - CervoMed

https://ir.cervomed.com/news-releases/news-release-details/cervomed-announces-new-clinical-plasma-biomarker-and-imaging

Jul 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next